申请人:AB Kabi
公开号:US04172093A1
公开(公告)日:1979-10-23
The present invention relates to new pharmacodynamically active compounds of the general structure ##STR1## as well as the corresponding amine oxides, quarternary ammonium compounds and salts with physiologically acceptable acids. In formula I R.sup.1 signifies hydrogen, halogen or alkoxy radicals having 1-3 carbon atoms, R.sup.2 and R.sup.3 signify alkyl radicals having 1-3 carbon atoms, which togetner with the carbon atom, to which they are connected, may form a ring, A either signifies a possibly lower alkyl substituted ethylene, trimethylene or tetramethylene group, in which case D is a group ##STR2## wherein R.sup.4 and R.sup.5 individually signify hydrogen or alkyl groups having 1-4 carbon atoms, or together with the nitrogen atom form a heterocyclic ring, which in addition to said nitrogen atom may contain an oxygen atom or possibly lower alkylated amino group, or A and B taken together signify a piperidino- or N-lower alkylpiperidino group, which is connected to an indene residue in 4-position, and the broken lines signify a double bond in either endo- or exo position.
本发明涉及一种新的具有药理活性的化合物,其一般结构为##STR1##以及相应的胺氧化物、季铵化合物和与生理可接受酸盐。在式I中,R.sup.1表示氢、卤素或具有1-3个碳原子的烷氧基,R.sup.2和R.sup.3表示具有1-3个碳原子的烷基基团,它们与它们连接的碳原子一起可以形成环,A表示可能低取代的乙烯基、三甲基乙烯基或四甲基乙烯基基团,此时D是一个基团##STR2##其中R.sup.4和R.sup.5分别表示氢或具有1-4个碳原子的烷基基团,或者与氮原子一起形成杂环,除了所述氮原子外,该杂环还可以含有一个氧原子或可能低烷基化的氨基基团,或者A和B一起表示连接到4-位置的吡啶基或N-低烷基吡啶基团,并且断裂的线表示内或外位置的双键。